secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABBOTT LABORATORIES (ABT)
CIK:        0000001800
Form:       8-K
Filed at:   2022-10-21T23:59:59+00:00
Accession:  0001104659-22-110612
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Abbott extends change-in-control agreements with named executive officers through Dec 2024
--------------------------------------------------------------------------------

- Extension moves expiration date from Dec 31, 2022 to Dec 31, 2024 for named executive officers.
- Agreements provide severance and other benefits upon a change in control of the company.
- Previously reported Agreements with executive officers extended by two years effective Oct 18, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800/000110465922110612/0001104659-22-110612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800/000110465922110612/tm2228558d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-110612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer